"Designing Growth Strategies is in our DNA"

U.S. Platelet Rich Plasma Market Size, Share & COVID-19 Impact Analysis, By Product (Pure Platelet Rich Plasma {Pure PRP}, Leukocyte-rich Platelet Rich Plasma {L-PRP}, Platelet Rich Fibrin {PRF}, and Others), By Application (Orthopedics, Neurology, Cosmetics, Wound Care, and Others), By End User (Hospital & ASCs, Specialty Clinics, and Others), and Country Forecast, 2023-2030

Last Updated: December 08, 2025 | Format: PDF | Report ID: FBI108787

 

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Prevalence of Key Chronic Diseases in the U.S., 2022
    2. Key Industry Developments
    3. Overview of Regulatory Scenario, By Key Regions
    4. Advancements in Platelet Concentrates
    5. Impact of Covid-19 on the Market
  5. U.S. Platelet Rich Plasma Market Analysis, Insights and Forecast, 2019-2030
    1. Market Analysis, Insights and Forecast – By Product
      1. Pure Platelet Rich Plasma (Pure PRP)
      2. Leukocyte-rich Platelet Rich Plasma (L-PRP)
      3. Platelet Rich Fibrin (PRF)
      4. Others
    2. Market Analysis, Insights and Forecast – By Application
      1. Orthopedics
      2. Neurology
      3. Cosmetics
      4. Wound Care
      5. Others
    3. Market Analysis, Insights and Forecast – By End User
      1. Hospitals & ASCs
      2. Specialty Clinics
      3. Others
  6. Competitive Analysis
    1. U.S. Market Share Analysis (2022)
    2. Company Profiles
      1. Arthrex, Inc.
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      2. Zimmer Biomet
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      3. Isto Biologics
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      4. ThermoGenesis Holdings, Inc.
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      5. Exactech, Inc.
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      6. EmCyte Corporation
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      7. Stryker
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      8. Medical Devices Business Services, Inc. (Johnson & Johnson Services, Inc.)
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      9. Terumo Corporation
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Prevalence of Key Chronic Diseases in the U.S., 2022
    2. Key Industry Developments
    3. Overview of Regulatory Scenario, By Key Regions
    4. Advancements in Platelet Concentrates
    5. Impact of Covid-19 on the Market
  5. U.S. Platelet Rich Plasma Market Analysis, Insights and Forecast, 2019-2030
    1. Market Analysis, Insights and Forecast – By Product
      1. Pure Platelet Rich Plasma (Pure PRP)
      2. Leukocyte-rich Platelet Rich Plasma (L-PRP)
      3. Platelet Rich Fibrin (PRF)
      4. Others
    2. Market Analysis, Insights and Forecast – By Application
      1. Orthopedics
      2. Neurology
      3. Cosmetics
      4. Wound Care
      5. Others
    3. Market Analysis, Insights and Forecast – By End User
      1. Hospitals & ASCs
      2. Specialty Clinics
      3. Others
  6. Competitive Analysis
    1. U.S. Market Share Analysis (2022)
    2. Company Profiles
      1. Arthrex, Inc.
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      2. Zimmer Biomet
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      3. Isto Biologics
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      4. ThermoGenesis Holdings, Inc.
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      5. Exactech, Inc.
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      6. EmCyte Corporation
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      7. Stryker
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      8. Medical Devices Business Services, Inc. (Johnson & Johnson Services, Inc.)
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      9. Terumo Corporation
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
Read Less

Table 01: U.S. Platelet Rich Plasma Market Revenue (USD million) Forecast, By Product, 2019–2030

Table 02: U.S. Platelet Rich Plasma Market Revenue (USD million) Forecast, By Application, 2019–2030

Table 03: U.S. Platelet Rich Plasma Market Revenue (USD million) Forecast, By End User, 2019–2030

Figure 01: U.S. Platelet Rich Plasma Market Revenue Breakdown (USD million, %) By Product, 2022 & 2030

Figure 02: U.S. Platelet Rich Plasma Market Value Share (%), By Product, 2022 & 2030

Figure 03: U.S. Platelet Rich Plasma Market Value Share (%), By Application, 2022 & 2030

Figure 04: U.S. Platelet Rich Plasma Market Value Share (%), By End User, 2022 & 2030

U.S. Platelet Rich Plasma Market
  • 2019-2030
  • 2022
  • 2019-2021
  • 70
Download Free Sample

    man icon
    Mail icon
    Captcha refresh
Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann

Related Reports